These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 9285106

  • 1. Treatment situation of hypertensive patients in Finnish primary health care.
    Kumpusalo E, Pärnänen H, Takala J.
    Blood Press Suppl; 1997; 1():35-9. PubMed ID: 9285106
    [Abstract] [Full Text] [Related]

  • 2. Prevalence of left ventricular hypertrophy in Finnish primary health care hypertensive patients.
    Kumpusalo E, Lappi J, Miettinen H, Takala J.
    J Hum Hypertens; 2001 Apr; 15(4):255-8. PubMed ID: 11319673
    [Abstract] [Full Text] [Related]

  • 3. High blood pressure despite treatment: results from a cross-sectional primary healthcare-based study in southern Sweden.
    Hedblad B, Nerbrand C, Ekesbo R, Johansson L, Midlöv P, Brunkstedt I, Svensson P, Gyllerup S, Sträng B, Persson R, Janzon L.
    Scand J Prim Health Care; 2006 Dec; 24(4):224-30. PubMed ID: 17118862
    [Abstract] [Full Text] [Related]

  • 4. Control of hypertension in Italy: results of the "Study on Antihypertensive Treatment in General Practice (STAP)". Physicians Taking Part in STAP.
    Avanzini F, Alli C, Colombo P, Corsetti A, Colombo F, Tognoni G.
    G Ital Cardiol; 1998 Jul; 28(7):760-6. PubMed ID: 9773300
    [Abstract] [Full Text] [Related]

  • 5. Treatment of hypertension in Finnish general practice seems unsatisfactory despite evidence-based guidelines.
    Varis J, Savola H, Vesalainen R, Kantola I.
    Blood Press; 2009 Jul; 18(1-2):62-7. PubMed ID: 19353413
    [Abstract] [Full Text] [Related]

  • 6. Gender differences in hypertension treatment, drug utilization patterns, and blood pressure control among US adults with hypertension: data from the National Health and Nutrition Examination Survey 1999-2004.
    Gu Q, Burt VL, Paulose-Ram R, Dillon CF.
    Am J Hypertens; 2008 Jul; 21(7):789-98. PubMed ID: 18451806
    [Abstract] [Full Text] [Related]

  • 7. Prevalence and management of hypertension in primary care in Portugal. Insights from the VALSIM study.
    Cortez-Dias N, Martins S, Belo A, Fiuza M, Investigadores do Estudo VALSIM.
    Rev Port Cardiol; 2009 May; 28(5):499-523. PubMed ID: 19650569
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG, Yao XY, Tao QM, Zheng P, Chen JZ, Zhu JH, Zhang FR, Zheng LR, Zhao LL.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [Abstract] [Full Text] [Related]

  • 10. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ, Ishola DA, Akintomide AO, Ajayi AA.
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [Abstract] [Full Text] [Related]

  • 11. Trends in hypertension care in eastern and south-western Finland during 1982-2002.
    Kastarinen MJ, Antikainen RL, Laatikainen TK, Salomaa VV, Tuomilehto JO, Nissinen AM, Vartiainen EA.
    J Hypertens; 2006 May; 24(5):829-36. PubMed ID: 16612243
    [Abstract] [Full Text] [Related]

  • 12. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
    Ohta Y, Tsuchihashi T, Onaka U, Eto K, Ueno M.
    Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
    [Abstract] [Full Text] [Related]

  • 13. Poor hypertension control in Greek patients with diabetes in rural areas. The VANK study in primary care.
    Skliros E, Sotiropoulos A, Vasibossis A, Xipnitos C, Chronopoulos I, Razis N, Merkouris P.
    Rural Remote Health; 2007 Apr; 7(3):583. PubMed ID: 17617008
    [Abstract] [Full Text] [Related]

  • 14. Prevalence, awareness and treatment of hypertension in Finland during 1982-2007.
    Kastarinen M, Antikainen R, Peltonen M, Laatikainen T, Barengo NC, Jula A, Salomaa V, Jousilahti P, Nissinen A, Vartiainen E, Tuomilehto J.
    J Hypertens; 2009 Aug; 27(8):1552-9. PubMed ID: 19412128
    [Abstract] [Full Text] [Related]

  • 15. [Evaluation on the effect of Benazepril for hypertension through postmarketing surveillance].
    Cao W, Li L, Hu Y, Zhan S, Li X, Li P, Wu T, Li J, Wang T.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Jun; 21(3):190-3. PubMed ID: 11860782
    [Abstract] [Full Text] [Related]

  • 16. Treatment of hypertension in Bahrain.
    Al Khaja KA, Sequeira RP, Damanhori AH.
    Ann Pharmacother; 2003 Oct; 37(10):1511-7. PubMed ID: 14519051
    [Abstract] [Full Text] [Related]

  • 17. Factors related to poor control of blood pressure with antihypertensive drug therapy.
    Jokisalo E, Enlund H, Halonen P, Takala J, Kumpusalo E.
    Blood Press; 2003 Oct; 12(1):49-55. PubMed ID: 12699136
    [Abstract] [Full Text] [Related]

  • 18. Queen Mary Utilization of Antihypertensive Drugs Study: side-effects of antihypertensive drugs.
    Cheung BM, Wong YL, Lau CP.
    J Clin Pharm Ther; 2005 Aug; 30(4):391-9. PubMed ID: 15985053
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and tolerability of the perindopril/indapamide combination therapy for hypertension: the PRIMUS study.
    Holzgreve H, Risler T, Trenkwalder P.
    Curr Med Res Opin; 2006 Sep; 22(9):1849-58. PubMed ID: 16968588
    [Abstract] [Full Text] [Related]

  • 20. Blood pressure levels, risk factors and antihypertensive treatments: lessons from the SHEAF study.
    Mallion JM, Genès N, Vaur L, Clerson P, Vaïsse B, Bobrie G, Chatellier G.
    J Hum Hypertens; 2001 Dec; 15(12):841-8. PubMed ID: 11773986
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.